Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.10 | 21.48 |
| PEG Ratio (TTM) | -5.90 | 2.29 |
| P/S Ratio (TTM) | 1.02 | 2.00 |
| P/B Ratio (TTM) | 1.55 | 3.50 |
| P/FCF Ratio (TTM) | 13.85 | 31.16 |
| Price to 5YR AVG Earnings Ratio | 10.31 | -199.64 |
| Price to 5YR AVG FCF Ratio | 11.19 | -75.60 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.57% | 8.67% |
| ROE (TTM) | 5.63% | 14.05% |
| Net Profit Margin (TTM) | 3.65% | 8.32% |
| ROIC 5YR AVG | 25.61% | 12.57% |
Growth (88%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 101.17% | 191.73% | 92.15% |
| Revenue | -2.88% | 22.89% | 5.74% |
| Net Income | 99.71% | 192.55% | 92.63% |
| Cash Flow | 277.96% | 227.75% | 606.42% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.68 | 3.18 |
| Quick Ratio (TTM) | 3.79 | 2.02 |
| D/E Ratio (TTM) | 0.00 | 0.57 |
| Interest Coverage (TTM) | 224.49 | 176.55 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 7.42 | 5.88 |
| LTL to 5YR AVG FCF | N/A | -31.18 |
| Shares Outstanding Growth 5YR AVG | 0.27% | -0.36% |